Estimation of Prostate Cancer Risk on the Basis of Total and Free Prostate-Specific Antigen, Prostate Volume and Digital Rectal Examination
- 1 June 2002
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 41 (6) , 619-627
- https://doi.org/10.1016/s0302-2838(02)00179-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Novel Artificial Neural Network for Early Detection of Prostate CancerJournal of Clinical Oncology, 2002
- Prostate-specific antigenSeminars in Cancer Biology, 1999
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- Development of a decision-making tool to predict risk of prostate cancer: The cancer of the prostate risk index (CAPRI) testUrology, 1997
- The Free-To-Total Prostate Specific Antigen Ratio Improves the Specificity of Prostate Specific Antigen in Screening for Prostate Cancer in the General PopulationJournal of Urology, 1997
- Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsJAMA, 1997
- Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screeningPublished by American Medical Association (AMA) ,1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Best Subsets Logistic RegressionBiometrics, 1989